Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|November 1, 2025
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trialMaeve A Lowery, Lucjan S Wyrwicz, Do-Youn Oh, et al.
The New England Journal of Medicine|September 13, 2013
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancerJean-Yves Douillard, Kelly S Oliner, Salvatore Siena, et al.
Cardiorenal Medicine|May 26, 2023
Prevalence, Clinical Characteristics, and Prognostic Impact of Kidney Disease on Heart Failure Patients: An Observational Study of the Colombian Heart Failure RegistryJuan David López-Ponce de León, Juan Esteban Gómez-Mesa, Clara Saldarriaga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung CancerSolange Peters, Sarina A Piha-Paul, Kartik Sehgal, et al.
Drugs & Aging|February 22, 2021
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled AnalysisPilar García-Alfonso, Eduardo Díaz-Rubio, Albert Abad, et al.
The Lancet. Oncology|November 22, 2012
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Eric Van Cutsem, Hans-Joachim Schmoll, et al.
The Lancet. Gastroenterology & Hepatology|January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A Philip, Jill Lacy, Fabienne Portales, et al.
Cardiology Research|March 11, 2024
Characteristics and Outcomes of Atrial Fibrillation in Chronic Heart Failure Patients: A Comprehensive Analysis of the Colombian Heart Failure RegistryAlex Rivera-Toquica, Clara Saldarriaga, Jannes Buelvas-Herazo, et al.
The Lancet. Oncology|April 4, 2021
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trialThierry Andre, Mayur Amonkar, Josephine M Norquist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B StudyJoana Vidal, Maria Concepción Fernández-Rodríguez, David Casadevall, et al.
Pageof 20